Peter J Openshaw
Overview
Explore the profile of Peter J Openshaw including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
2159
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Michael B, Dunai C, Needham E, Tharmaratnam K, Williams R, Huang Y, et al.
Nat Commun
. 2024 Apr;
15(1):2918.
PMID: 38575615
No abstract available.
2.
Michael B, Dunai C, Needham E, Tharmaratnam K, Williams R, Huang Y, et al.
Nat Commun
. 2023 Dec;
14(1):8487.
PMID: 38135686
To understand neurological complications of COVID-19 better both acutely and for recovery, we measured markers of brain injury, inflammatory mediators, and autoantibodies in 203 hospitalised participants; 111 with acute sera...
3.
Killingley B, Mann A, Kalinova M, Boyers A, Goonawardane N, Zhou J, et al.
Nat Med
. 2022 Apr;
28(5):1031-1041.
PMID: 35361992
Since its emergence in 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused hundreds of millions of cases and continues to circulate globally. To establish a novel SARS-CoV-2 human...
4.
Kohns Vasconcelos M, Loens K, Sigfrid L, Iosifidis E, Epalza C, Dona D, et al.
BMJ Open Respir Res
. 2021 Jul;
8(1).
PMID: 34326154
Background: Both pathogenic bacteria and viruses are frequently detected in the nasopharynx (NP) of children in the absence of acute respiratory infection (ARI) symptoms. The aim of this study was...
5.
Paterson S, Kar S, Ung S, Gardener Z, Bergstrom E, Ascough S, et al.
Am J Respir Crit Care Med
. 2021 Jul;
204(7):826-841.
PMID: 34256007
Suboptimal vaccine immunogenicity and antigenic mismatch, compounded by poor uptake, means that influenza remains a major global disease. T cells recognizing peptides derived from conserved viral proteins could enhance vaccine-induced...
6.
Salimi V, Viegas M, Trento A, Agoti C, Anderson L, Avadhanula V, et al.
Emerg Infect Dis
. 2021 May;
27(6):1-9.
PMID: 34013862
Human respiratory syncytial virus (HRSV) is the leading viral cause of serious pediatric respiratory disease, and lifelong reinfections are common. Its 2 major subgroups, A and B, exhibit some antigenic...
7.
Wiseman D, Thwaites R, Drysdale S, Janet S, Donaldson G, Wedzicha J, et al.
J Infect Dis
. 2020 Apr;
222(Suppl 7):S584-S591.
PMID: 32227102
Background: Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis in young infants. However, it is also a significant pathogen in older adults. Validated biomarkers of RSV disease...
8.
Goya S, Galiano M, Nauwelaers I, Trento A, Openshaw P, Mistchenko A, et al.
Influenza Other Respir Viruses
. 2020 Feb;
14(3):274-285.
PMID: 32022426
Background: Human respiratory syncytial virus (RSV) is classified into antigenic subgroups A and B. Thirteen genotypes have been defined for RSV-A and 20 for RSV-B, without any consensus on genotype...
9.
Guvenel A, Jozwik A, Ascough S, Ung S, Paterson S, Kalyan M, et al.
J Clin Invest
. 2019 Dec;
130(1):523-538.
PMID: 31815739
BACKGROUNDRespiratory syncytial virus (RSV) is an important cause of acute pulmonary disease and one of the last remaining major infections of childhood for which there is no vaccine. CD4+ T...
10.
Thwaites R, Openshaw P
Am J Respir Crit Care Med
. 2019 Aug;
200(11):1340-1342.
PMID: 31412707
No abstract available.